Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Organon & Co. Director's Dealing 2026

Mar 3, 2026

31461_dirs_2026-03-03_29dac463-73ce-4ce0-ba47-408a167c5db4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Organon & Co. (OGN)
CIK: 0001821825
Period of Report: 2026-02-27

Reporting Person: Falcione Aaron (Chief Human Resources Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-27 Common Stock A 23805 Acquired 86778.661 Direct
2026-02-27 Common Stock F 8705 $7.17 Disposed 78073.661 Direct
2026-02-27 Common Stock A 6717 Acquired 84790.661 Direct
2026-02-27 Common Stock F 2301 $7.23 Disposed 84109.071 Direct

Footnotes

F1: Represents shares of Organon & Co. common stock ("Common Stock") for performance share units ("PSUs") granted to the reporting person on August 11, 2023 under the Organon & Co. 2021
Incentive Stock Plan. The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of
Directors.

F2: Represents the shares of Common Stock released to cover the dividend equivalents earned on the PSUs released above.

F3: Includes the addition of 1,619.41 shares of Common Stock acquired from dividend equivalents net of withholding tax not previously required to be reported.